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Many neurotransmitters, hormones, and sensory stimuli elicit their cellular responses
through the targeted activation of receptors coupled to the Gαq family of heterotrimeric
G proteins. Nevertheless, we still understand little about the consequences of loss of
this signaling activity on brain function. We therefore examined the effects of genetic
inactivation of Gnaq, the gene that encode for Gαq, on responsiveness in a battery of
behavioral tests in order to assess the contribution of Gαq signaling capacity in the brain
circuits mediating expression of affective behaviors (anxiety and behavioral despair), spatial
working memory, and locomotor output (coordination, strength, spontaneous activity, and
drug-induced responses). First, we replicated and extended findings showing clear motor
deficits in Gαq knockout mice as assessed on an accelerating rotarod and the inverted
screen test. We then assessed the contribution of the basal ganglia motor loops to these
impairments, using open field testing and analysis of drug-induced locomotor responses
to the psychostimulant cocaine, the benzazepine D1 receptor agonists SKF83822 and
SKF83959, and the NMDA receptor antagonist MK-801. We observed significant increases
in drug-induced locomotor activity in Gαq knockout mice from the dopaminergic agonists
but not MK-801, indicating that basal ganglia locomotor circuitry is largely intact in the
absence of Gαq. Additionally, we observed normal phenotypes in both the elevated zero
maze and the forced swim test indicating that anxiety and depression-related circuitry
appears to be largely intact after loss of Gnaq expression. Lastly, use of the Y-maze
revealed spatial memory deficits in Gαq knockout mice, indicating that receptors signaling
through Gαq are necessary in these circuits for proficiency in this task.
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INTRODUCTION
A large number of neurotransmitter receptors containing seven
transmembrane domains, including the group I metabotropic
glutamate receptors mGluR1 and mGluR5, α1 adrenergic recep-
tors, and 5HT2 serotonergic receptors, mediate their physiological
responses by activating heterotrimeric GTP-binding (G-) proteins
with alpha subunits in the Gq family (Gαq) (Pin and Duvoisin,
1995; Millan et al., 2008; Cotecchia, 2010; Ribeiro et al., 2010).
The Gαq family consists of four members: Gαq, Gα11, Gα14, and
Gα15/16; of which Gαq and Gα11 represent the major isoforms in
the adult brain (Strathmann and Simon, 1990;Wilkie et al., 1991).
These proteins are co-expressed almost ubiquitously in the central
nervous system, share 88% amino acid sequence homology and
couple receptor stimulation to the activation of phospholipase
C (PLC)-β isoforms, phosphatidylinositol (PI) hydrolysis, and
downstream second messenger signaling systems (Strathmann
and Simon, 1990; Smrcka et al., 1991; Taylor et al., 1991; Mailleux
et al., 1992; Offermanns et al., 1994; Exton, 1996). Although
Gαq and Gα11 are expressed together in almost every cell type,
the relative levels of expression vary across brain regions with
Gαq expression being 2–5 times higher than Gα11 in most areas
(Milligan, 1993). Given that the functions of these two pro-
teins are largely redundant, genetic inactivation of both Gnaq
and Gna11, the genes that encode for Gαq and Gα11 respectively,
results in embryonic lethality at embryonic day 10.5 (Offermanns
et al., 1998). Genetic inactivation of either Gαq or Gα11 results in
mice that are viable with more pronounced phenotypes observed
in the Gαq knockouts, which harbor impairments in cerebel-
lar maturation, motor coordination, and primary hemostasis
(Offermanns et al., 1997a,b, 1998).
Gross anatomical deficits in the morphology and development
of the nervous system have not been reported in Gαq knock-
out mice other than postnatal alterations in the innervation of
the cerebellum (Offermanns et al., 1997b). As such, loss of Gαq-
mediated synaptic pruning in the cerebellum has been suggested
to underlie the altered behavioral output in motor function and
ataxia observed in these animals. These findings raise the ques-
tion of whether deficits in Gαq signaling in forebrain locomotor
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circuitry may also be involved. In these circuits, dopaminergic
axons from the substantia nigra (SN) pars compacta innervate
GABAergic medium spiny neurons (MSNs) in the dorsal stria-
tum (caudate putamen). Also forming synaptic contacts on the
dendritic arbors of the MSNs are descending corticostriatal gluta-
matergic inputs and those projections coming from the thalamus.
MSNs in the dorsal striatum are largely segregated into two pop-
ulations based on expression of dopamine receptors and axonal
projections. MSNs expressing dopamine D1 receptors project
directly to the SN pars reticulata while those expressing D2
receptors project to the SN pars reticulata via an indirect route
involving intermediate synapses in the globus pallidus and the
subthalamic nucleus. The SN pars reticulata then relays signals
to the thalamus and motor cortex (stimulatory in the case of the
direct pathway or inhibitory from the indirect) for the control
of voluntary movement (Gerfen, 1992; Albin et al., 1995; Shuen
et al., 2008). The thalamus andmotor cortex are points of conver-
gence between the cerebellar and basal ganglia circuits (Nakano,
2000), suggesting that deficits in either or both of these circuits
could result in motor deficits from loss of Gαq signaling. In fact,
Gαq is highly expressed in both the caudate putamen and the
cerebellum (Mailleux et al., 1992).
Recent evidence also suggests that dopamineD1-like receptors,
which are typically thought of as coupling with Gαs/olf, may also
be capable of coupling to Gαq (Wang et al., 1995; Jin et al., 2001).
Additionally, given the broad diversity in receptors that couple to
Gαq and the range in biological processes in which these recep-
tors are involved, there may be other circuits that are behaviorally
relevant that might be impacted by constitutive loss of Gαq sig-
naling. For example, the prefrontal cortex, a brain region that
has been shown to directly regulate working memory and other
cognitive functions (Goldman-Rakic, 1995; Chudasama, 2011;
Kesner and Churchwell, 2011) as well as influencing a variety of
other behaviors including mood regulation and emotional pro-
cessing (Drevets et al., 2008; White et al., 2009; Etkin, 2010), also
expresses high levels of Gαq protein (Milligan, 1993). The func-
tions of the prefrontal cortex have been previously shown to be
sensitive to local changes in neurochemical content and receptor
signaling (Rinaldi et al., 2007; Vijayraghavan et al., 2007; Arnsten,
2011). Here, we address these questions andmore precisely define
the phenotype and drug responsivity of Gαq knockout mice using
a systems-level approach.
METHODS
ANIMALS
The generation of Gαq knockout mice has previously been
described (Offermanns et al., 1997b). For the present exper-
iments, heterozygous Gαq males were mated to heterozygous
females to generate litters containing wildtype, heterozygous,
and knockout mice. The genotypes of all mice were determined
by polymerase chain reaction (PCR) analysis of genomic DNA
obtained from tail biopsies using methods previously described
with minor adaptations (Offermanns et al., 1997b; Stanwood
et al., 2005). For each experiment, an average of 6–24 wildtype,
6–20 heterozygous, and 6–15 knockout mice were analyzed with
the exception of the forced swim test in which four knockoutmice
were analyzed. Tail biopsies were obtained at the time of weaning,
postnatal day (P)21, for initial assignment of genotypes and once
again at the time of sacrifice for confirmation.
Male mice were housed in cages of 2–5 with their littermates
under standard housing conditions on a 12 h light/dark cycle
(lightson0600–1800 h)withad libitum foodandwater.Their cages
contained environmental enrichment huts (Otto Environmental,
Milwaukee,WI) and their diet was high-energy irradiated LabDiet
5LJ5 (Tusculum, Nashville, TN). All behavioral testing was con-
ducted during the light phase on mice that were at least (P)60 at
the time of initial testing. Mice were extensively handled for at
least 1 week prior to the beginning of testing and were habituated
to the testing rooms for ∼30min prior to beginning of every
experiment. Mice were also weighed prior to the beginning of
each experiment and there were no significant changes in weight
as a result of the behavioral testing. All procedures were approved
by the Vanderbilt University Animal Care and Use Committee.
DRUGS
The drugs used in this study were the dopamine D1-like receptor
agonists SKF83959 (3-methyl-6-chloro-7,8-dihydroxy-1-[3-
methylphenyl]-2,3,4,5-tetrahydro-1H-3-benzazepine; Tocris
Biosciences, Minneapolis, MN) used at 1mg/kg and SKF83822
([R/S]-6-chloro-7, 8-dihydroxy-3-allyl-1-[3-methyl-phenyl]-2,-
3,4,5-tetrahydro-1H-3-benzazepine, NIMH Chemical Synthesis
Program, Research Triangle Park, NC) used at 0.4mg/kg.
Additionally, the NMDA receptor antagonist MK-801 ([5R,10S]-
(+)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-
imine hydrogen maleate, Sigma, St. Louis, MO) was used at
0.2mg/kg and cocaine HCl (NIH/NIDA, Bethesda, MD) was
used at 30mg/kg. All drugs were dissolved in 0.9% saline and
injected intraperiotoneally (i.p.).
ROTAROD
Motor coordination and balance were measured using a commer-
cially available accelerating rotarod apparatus (Ugo Basile model
7650, Collegeville, PA). Mice were placed on the rotating cylin-
der (3 cm in diameter) and confined to a section approximately
6.0 cm long by gray plastic dividers. The rotational speed of the
cylinder was increased from 5 to 40 rpm over a 5min period. The
latency at which mice fell off the rotating cylinder was measured.
Each mouse was tested on three independent trials per day (with
a 15min inter-trial period) over a 3 day testing period.
INVERTED SCREEN
For the inverted screen test, 2–4 littermates were placed on ametal
grid screen (10 × 14 cm) with separate compartments. After
placement, the mice were allowed time to grip the grid before
it was inverted 60 cm over a plastic cage containing fresh bed-
ding. Latency to fall was recorded up to 60 s, at which point mice
were removed from the apparatus and returned to the home cage.
Three independent trials were conducted approximately 15min
apart on 1 day of testing, and data from all three trials were
averaged together.
ELEVATED ZERO MAZE
The elevated zero maze is a modification of the elevated plus
maze used for assessing anxiety-related behaviors. Use of the cir-
cular maze removes any ambiguity in data interpretation as there
Frontiers in Behavioral Neuroscience www.frontiersin.org June 2012 | Volume 6 | Article 29 | 2
Frederick et al. Behavior of Gαq null mice
is no center zone (Lister, 1990; Shepherd et al., 1994; Rodgers
et al., 1997). The elevated circular platform (40 cm off the ground,
50 cm in diameter) had two enclosed arenas opposite each other
(5 cm wide with 15 cm high walls) and two open arenas (5 cm
wide). At the start of the test, each mouse was lowered by its
tail into the open arena of the maze and allowed to explore the
maze for 300 s. Activity of the mouse was monitored via an over-
head camera connected to a computer in a separate room using
video acquisition and ANY-maze analysis software (Stoelting,
Wood Dale, IL). Data analyzed included percentage of time spent
in the open versus closed arenas and the total distance traveled
in the maze.
Y-MAZE
The Y-maze containing three clear arms (34.5 × 5.2 cm) joined in
the center was placed on an opaque table about 91 cm above the
ground in a room containing several large immovable objects to
use as spatial cues. At the start of the test, each mouse was low-
ered by its tail into the center junction of the maze and allowed
to explore the maze for 360 s. Activity of the mouse was mon-
itored via an overhead camera connected to a computer in a
separate room using video acquisition and ANY-maze analysis
software (Stoelting, Wood Dale, IL). The sequence of individual
arm entries was scored by the observer in real time and used to
calculate the percentage of spontaneous alternations for each ani-
mal (consecutive entry into each of the three arms) as previously
described (Thompson et al., 2005). The Y-maze assesses spa-
tial working memory as animals tend to alternate between arms
based on their memory of the previously visited arms. Chance
performance is 22.2% in this paradigm.
FORCED SWIM TEST
Behavioral despair was assessed in the forced swim test using plas-
tic cylinders (50 cm in diameter, 21 cm in height) filled approxi-
mately three-fourth full with room temperature water. Mice were
individually placed into the cylinder for a 6min test and were
recorded on video for the duration of the test. After testing, the
mice were placed into a heating cage to dry before returning to
the home cage. The water was changed between tests and the tem-
perature of the water was recorded. Videos were later analyzed for
time spent immobile for each mouse by an observer blinded to
genotype.
OPEN FIELD
Locomotor activity in a novel open field and locomotor responses
to SKF83959, SKF83822, cocaine, and MK-801 were measured
using commercial open field activity chambers (Med Associates,
29 × 29 × 20.5 cm) that were contained within light- and air-
controlled environmental chambers (Med Associates, St. Albans,
VT; 64 × 45 × 42 cm) (Stanwood and Levitt, 2007). Location and
movement were detected by the interruption of infrared beams
by the body of the mouse (16 photocells in each horizontal direc-
tion, as well as 16 photocells elevated 4 cm to measure rearing)
and were measured by the Med Associates Activity Monitoring
program. On Days 1 and 2 of testing, mice were placed into
activity chambers for 30min for baselinemeasurements, removed
from the chambers, injected with 0.9% saline, and returned to the
chambers for 60min. On Day 3 of testing, the mice were injected
with SKF83959 (1mg/kg) instead of 0.9% saline. This extended
protocol was designed to extensively habituate the mice to the
chambers before drug administration. For testing of additional
compounds, a 2-day protocol was implemented where the mice
received 0.9% saline on Day 1 and the test compound (0.4mg/kg
SKF83822, 0.2mg/kgMK-801 or 30mg/kg cocaine; i.p.) onDay 2.
Experiments were conducted at least 1 week apart and animals
were handled during the period of time during which they were
not tested. For simplicity of analysis and display, the baseline
and post-injection periods were averaged and are represented as
bar graphs.
DATA ANALYSIS AND STATISTICS
Except when otherwise noted, data were subjected to one- or-
two way analysis of variance (ANOVA) using genotype as a
between-group factor using GraphPad Prism. Post-hoc Tukey’s
Multiple Comparison Tests were used to compare groups to each
other except for the rotarod analysis, where Bonferroni com-
parisons were employed. Normality was not observed within
the inverted screen dataset, due to many null mice imme-
diately falling from the screen. For these data, therefore, a
nonparametric Kruskal-Wallace test and post-hoc Dunn’s com-
parisons were employed. Graphs are marked with an asterisk
(∗) to denote statistical significance (p < 0.05). For data with
p < 0.01 or p < 0.001, the graphs are marked with two (∗∗)
or three (∗∗∗) asterisks, respectively. For data with a p > 0.05
but less than p = 0.20, the data was noted as exhibiting a
trend. In the inverted screen test, genotype differences were
assessed by unpaired Student’s t-test with significance defined as
two-tailed p < 0.05.
RESULTS
Gαq KNOCKOUT MICE EXHIBIT ALTERATIONS IN BODY WEIGHT
Visual inspection revealed that Gαq knockout mice are sig-
nificantly smaller than their wildtype littermates (Figure 1A).
Figure 1B shows the average weights of adult Gαq null, het-
erozygous, and wildtype mice at the start of behavioral testing.
Consistent with their smaller sizes, Gαq knockout mice weigh
almost half as much as wildtype mice [F(2, 28) = 12.33, p <
0.001] and this phenotype is maintained across their lifespan
(data not shown).
ABNORMAL MOTOR FUNCTION IN Gαq KNOCKOUT MICE
Mice homozygous for a deletion in Gαq have previously been
described as exhibiting deficits in motor function including loss
of balance during walking and rearing, spastic, and uncontrolled
movements and ataxia upon visual inspection (Offermanns et al.,
1997b and data not shown). Quantifiable deficits in motor func-
tion and coordination are revealed on an accelerating rotarod
where Gαq knockout mice fell from the device in significantly
less time than controls on each of three consecutive testing days
(Figure 2A; factorial ANOVA, post-hoc Bonferroni comparisons
p < 0.05 on Day 1, p < 0.01 on Days 2 and 3), confirming
previous findings (Offermanns et al., 1997b). There were also
significant differences in performance observed between the het-
erozygous and null mice on each day of testing (Figure 2A;
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FIGURE 1 | Weight analysis. Gαq knockout mice are smaller than their
wildtype littermates as shown in the photomicrograph in (A). (B) shows the
average weight of each genotype at the time of initial testing (∼2–3
months of age). Gαq knockout mice weigh significantly less than wildtype
[F(2, 28) = 12.33, p < 0.001] and heterozygous [F(2, 28) = 12.33, p < 0.01]
mice and this phenotype is maintained throughout the life of the
animals (data not shown). Each column represents the average of 8–12
animals.
FIGURE 2 | Rotarod and inverted screen tests. Gαq knockout mice spend
significantly less time on an accelerating rotarod than their wildtype and
heterozygous littermates (A; p < 0.05 between the knockouts and the other
two genotypes on day 1 of testing; p < 0.01 on days 2 and 3 by Two-Way
ANOVA with Bonferroni post-hoc comparison test). n = 6 for each genotype
and each individual animal was tested in three trials on three consecutive
days of testing. The data shown here represents the three trial averages
across genotypes on each day of testing. (B) shows the latency of each
genotype to fall from an inverted screen. Wildtype and heterozygous mice
are able to grip the screen almost three times longer than Gαq null mice
indicating reduced muscle and/or grip strength in the knockouts (overall p <
0.0001 by Kruskal–Wallis test; null mice are significantly different from both
wildtype and heterozygote mice by Dunn’s test, p < 0.05). Each column
represents the average of 13–22 animals.
p < 0.05 on Day 1, p < 0.001 on Days 2 and 3) with no
significant differences between the heterozygous and wildtype
mice. Similarly, Gαq knockoutmice performed significantly worse
than wildtype and heterozygous animals on an inverted screen
test, confirming motor, and/or coordination impairments in the
null animals (p < 0.05; Figure 2B).
Gαq KNOCKOUT MICE APPEAR NORMAL IN TESTS OF ANXIETY
AND BEHAVIORAL DESPAIR
Gαq knockout mice exhibited a significant hypolocomotive phe-
notype in the elevated zero maze as evidenced by the reduction
in total ambulatory distance traveled in the maze compared
to wildtype and heterozygote animals (Figure 3A). Both Gαq
knockout and wildtype mice spent significantly more time in
the closed arenas than the open arenas with no significant dif-
ference between the genotypes with respect to the percentage
of time spent in the open (33.9 ± 3.8% for wildtype, 25.3 ±
6.1% for Gαq knockout) or closed arenas (66.1 ± 3.8% for wild-
type, 74.7 ± 6.1% for Gαq knockout) of the maze (Figure 3B).
This is consistent with previous reports suggesting that wild-
type mice spend approximately 20–30% of their time in the
open arenas of the zero maze (Shepherd et al., 1994). Although
not statistically significant [F(2, 32) = 2.3, p = 0.11], heterozy-
gous animals spent somewhat more time in the open arenas
(42.1 ± 6.8%) than the other two genotypes. While in the
open arenas, wildtype, and heterozygous animals traveled at
significantly faster speeds than the knockout mice (Figure 3C;
F(5, 30) = 8.5, p < 0.001) whichmoved slower in themaze overall
(Figure 3D; F(2, 33) = 11.96, p < 0.001) compared to the other
two genotypes.
Figure 4 displays the results of the forced swim test, a com-
monly used assay of behavioral despair used to predict the
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FIGURE 3 | Elevated zero maze. Gαq knockout mice exhibit a hypoactive
phenotype on the elevated zero maze and travel significantly less
distance in the maze than their wildtype and heterozygous littermates
(A; F(2, 15) = 16.55, p < 0.001). There is not a significant difference between
the genotypes in the percentage of time spent in the open areas
(B) indicating a normal anxiety phenotype in the null mice. n = 12 for wildtype
and heterozygous mice, n = 11 for knockout mice in these experiments.
While in the open arenas, wildtype, and heterozygous mice move at
significantly faster speeds than knockout mice (C; F(5, 30) = 8.5, p < 0.001),
which move slower in the maze overall (D; F(2, 33) = 11.96, p < 0.001).
FIGURE 4 | Forced swim test. Forced swim test analysis reveals no
significant differences (p > 0.05) between the genotypes in this assay of
behavioral despair. Each column represents the average of 4–6 animals.
antidepressant potential of compounds or drug targets in animal
models (Porsolt et al., 1977; Shepherd et al., 1994). The forced
swim test revealed no significant differences between the geno-
types, indicating that loss of Gαq protein expression does not
confer antidepressant effects.
Gαq KNOCKOUT MICE EXHIBIT DEFICITS IN SPATIAL WORKING
MEMORY
Gαq knockout mice again exhibited significant hypoactivity in
the Y-maze as evidenced by the significant reduction in total
arm entries committed by this genotype compared heterozygous
and wildtype littermates (Figure 5A). In addition, acquisition
of this spatial task was severely impaired in Gαq knockouts
compared to wildtype [F(2, 4) = 13.3, p < 0.001]. Gαq knockout
mice exhibited a significant reduction in the number of sponta-
neous alternations (entry of the maze’s three arms in sequence),
and the percentage of alternations, a measure which takes into
account the hypoactive phenotype of the Gαq null mice in this
task (Figures 5B,C). Wildtype animals spontaneously alternated
at 62.5 ± 2.9% compared to 44.1 ± 7.5% observed in Gαq
knockout mice.
DRUG-INDUCED LOCOMOTOR RESPONSES APPEAR INTACT IN
Gαq KNOCKOUT MICE
In order to gauge the integrity of basal ganglia locomotor circuitry,
we investigated the spontaneous locomotor activity of Gαq knock-
out, heterozygous, and wildtype mice in open field chambers and
their acute locomotor response to pharmacological compounds
known to modulate locomotor output (primarily by modulat-
ing dopaminergic signaling in basal ganglia circuits). Our data
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FIGURE 5 | Y-maze test. In this test of spatial working memory, the
reduced number of arms entered by Gαq knockout mice compared to
wildtype and heterozygous littermates again reveals a hypoactive
phenotype (A). In addition, acquisition of this spatial task was severely
impaired in Gαq knockout mice which exhibited a significant reduction in the
number of spontaneous alternations (B; F(2, 44) = 14.42, p < 0.001) and
percentage of alternations (C; F(2, 44) = 4.44, p < 0.05 between wildtype
and null) in this task. Percentage of alternations was determined by dividing
the number of alternations by the number of possible alternations [(# total
arm entries − 2) × 100], thereby taking into account the locomotor
phenotype of Gαq knockout mice. Each column represents the average of
12–18 animals.
show that in a novel open field, Gαq knockout mice are initially
hypoactive compared to their wildtype and heterozygous litter-
mates (as assessed by distance traveled) and travel significantly
less distance than wildtype animals during the 90min session
(Figure 6A; F(2, 30) = 4.2, p < 0.05). These data further support
our earlier observations regarding the activity level of the null
animals in both the elevated zero and Y-maze tasks. On the second
day of habituation (Figure 6B), as the wildtype and heterozygous
animals acclimate further to the chambers and reduce their level
of activity, there is no longer a significant difference in the total
distance traveled by each genotype, although there is still a trend
[F(2, 31) = 4.2, p = 0.16] toward hypoactivity in the null mice.
Drug-induced locomotor responses were first assessed using
cocaine, a prototypical psychomotor stimulant that increases
locomotor activity by blocking high affinity monoamine trans-
porters. Figure 7A shows the ambulatory distance traveled by
each genotype as a function of time in the open field cham-
ber. The first 30min represent the baseline period during which
the animals were allowed time to habituate to the chamber
and the last 60min (minutes 35–90 on the graph) represent
the post-injection period. The data for the baseline and post-
injection periods are then averaged and displayed as Figure 7B.
These data illustrate that injection of 30mg/kg cocaine (i.p.)
elicited a significant locomotor response in all three genotypes
relative to the pre-injection baseline period [F(5, 21) = 186.0,
p < 0.001]. The raw distance traveled for the knockout mice
in the post-injection period, however, was significantly reduced
compared to responses observed in both the wildtype and het-
erozygous animals [F(5, 21) = 186.0, p < 0.001]. There was also
a small but significant blunting of the post-injection response of
the heterozygous animals [F(5, 21) = 186.0, p < 0.001]. However,
when normalized for percentage change from baseline, there were
no significant differences between the genotypes. If anything,
there was a trend [F(2, 25) = 2.23, p = 0.13] toward a greater per-
centage change from baseline in the null animals because their
baseline activity was very low (Figure 7C). Taken together, these
results indicate that the cocaine-induced locomotor response is
largely intact in Gαq knockout mice, despite their profound basal
hypoactivity.
Next, we assessed the locomotor responses to direct stimula-
tion of dopamine D1 receptors by the high affinity benzazepine-
derived agonist SKF83822. SKF83822 has been reported to
activate dopamine D1 receptors coupled to Gαs/olf and down-
stream cyclase activity (Undie et al., 1994; Rashid et al., 2007).
Behaviorally, SKF83822 has been shown to produce a locomotor
response in both rodent and non-human primate models with-
out affecting stereotypy, intense grooming, or dyskinesia (Peacock
and Gerlach, 2001; O’Sullivan et al., 2004). In our analyses, an
acute injection of SKF83822 (0.4mg/kg; i.p.) induced a greater
than threefold increase in locomotor activity relative to the base-
line period for each genotype (Figures 8A,B; F(5, 18) = 139.2,
p < 0.001). Again, as observed with acute cocaine, there were
significant differences between the post-injection response of the
knockout animals compared to their wildtype and heterozygous
littermates (Figure 8B; F(5, 18) = 139.2, p < 0.001) without sig-
nificant changes in the percentage change from baseline between
the genotypes (Figure 8C).
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FIGURE 6 | Open field test. Locomotor activity in a novel open field was
assessed. (A,B) show the ambulatory distance traveled as a function of time
(5min blocks over a 90min testing period) by each genotype on 2 days of
habituation. Mice were removed from the chamber after 30min and
administered 0.9% saline (i.p.) before returning to the chamber for the last
60min of testing. The inset in each panel shows the total distance traveled
by each genotype, which is significantly reduced for Gαq knockout mice on
day 1 (A; F(2, 30) = 4.2, p < 0.05). n = 12–18 for each genotype.
We then assessed a second benzazepine-derived D1 receptor
agonist, SKF83959, for activity in the open field. Unlike
SKF83822, SKF83959 has been reported to antagonize dopamine-
mediated stimulation of adenylyl cyclase (Arnt et al., 1992;
Andringa et al., 1999; Cools et al., 2002; Jin et al., 2003) and may
preferentially activate D1 receptors linked to stimulation of PI
hydrolysis (Arnt et al., 1992; Panchalingam and Undie, 2001; Jin
et al., 2003). Initial studies assessing the locomotor response to
varying doses of SKF83959 suggested that 1mg/kg (i.p.) elicited
a maximal response in wildtype mice (data not shown). This
response was still fairly modest, however, and increased locomo-
tor activity approximately twofold over the baseline level (data
not shown). In response to an acute injection of SKF83959
(1mg/kg; i.p.), we again observed significant increases in post-
injection locomotor responses in wildtype, heterozygous, and
knockout mice (Figures 9A,B; F(5, 18) = 123.9, p < 0.001). We
did observe significant differences in the post-injection response
of the knockout animals compared to the wildtype and heterozy-
gous animals [F(5, 18) = 123.9, p < 0.001], however the magni-
tude of the locomotor response was more robust in the knock-
out [F(2, 33) = 7.0, p < 0.05] and heterozygous [F(2, 33) = 7.0,
p < 0.001] animals compared to wildtype when considering the
percentage change from baseline (Figure 9C).
Lastly, we set out to evaluate locomotor activity by modulating
glutamatergic input with the non-competitive N-Methyl-D-
Aspartate (NMDA) receptor antagonist MK-801. In response to
acute MK-801 (0.2mg/kg; i.p.), we observed significant increases
in post-injection locomotor responses in wildtype and Gαq het-
erozygotes [F(5, 36) = 9.8, p < 0.05] but not in Gαq knockout
mice (Figures 10A,B). There were however, as observed previ-
ously with all compounds tested, significant differences between
the post-injection response of the knockout animals compared
to their wildtype [F(5, 36) = 9.8, p < 0.001] and heterozygous
[F(5, 36) = 9.8,p < 0.01] littermates (Figure 10B) followingacute
MK-801. Similarly, as observed with all compounds tested except
SKF83959, there were no significant changes in the percentage
change from baseline between the genotypes (Figure 10C).
DISCUSSION
As predicted, Gαq knockout mice performed significantly worse
than wildtype mice on tests of motor coordination and strength
revealing a phenotypic motor dysfunction in these animals. These
results confirm the visual phenotype of the null mice which hints
at ataxia, inability to coordinate movements, and uncontrolled
locomotion. Gαq knockout mice are also much smaller and weigh
less than heterozygous or wildtype mice.
Motor impairments in Gαq knockout mice could result from
deficits in motor circuits controlled by cerebellar output as previ-
ously hypothesized (Offermanns et al., 1997b) and/or the involve-
ment of other motor pathways including those involving the basal
ganglia locomotor circuitry, which we assessed indirectly using
locomotor stimulant drugs. In attempting to holistically evaluate
Gαq knockout mice for circuit-level deficits in brain function, we
used simple, well-defined behavioral paradigms to probe the con-
tribution of Gαq signaling capacity in complex behaviors that may
be relevant to mental health disorders.
Anxiety and depression, for example, are two common emo-
tional disorders accounting for a substantial proportion of the
burden of mental health disorders in the United States (Weissman
et al., 1996; Kessler et al., 2005). Although the neural circuits
underlying these disorders are not completely understood, dys-
functions in the amygdala, hippocampus, basal ganglia, and
prefrontal cortex are commonly implicated (Clark et al., 2009;
Aupperle and Paulus, 2010; Clark and Beck, 2010; Harro et al.,
2011; McEwen et al., 2012). In the elevated zero maze, a useful
task for assessing anxiety-related behavior in rodent models, we
saw no significant differences between the genotypes with respect
to the percentage of time spent in the open arenas. These results
indicate a normal anxiety-like phenotype in the knockout mice
although we do not know if there are compensations within the
circuit from global loss of Gαq that result in lack of an observed
phenotype. Additionally, we observed no significant differences in
the forced swim test assessing depressive-like phenotypes. These
results were unexpected as there is evidence in the literature
suggesting that inhibiting the PLC—protein kinase C signaling
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FIGURE 7 | Locomotor response to acute cocaine. We investigated the
integrity of locomotor responses to variety of pharmacological compounds
with the ability to modulate dopaminergic signaling (directly or indirectly)
and motor output. (A) shows the ambulatory distance traveled as a
function of time (5min blocks over a 90min testing period) by each
genotype during a 30min baseline period and 60min after the animals were
injected with cocaine (30mg/kg; i.p.). The data is represented as bar graphs
in (B) with the data from min 10–30 collapsed for each genotype as the
baseline measurement and min 40–60 representing the post-injection
period. There is a significant increase in locomotor activity in each genotype
following exposure to cocaine, however there is a significant difference
between the post-injection locomotor response of the knockout mice
compared to the other two genotypes [F(5, 21) = 186.0, p < 0.001]. The
percentage change from baseline for each genotype is displayed in (C) with
no significant changes. n = 6–12 for each genotype in these experiments.
transduction pathway or intracellular calcium release (which can
be activated by Gαq-coupled receptors) produces antidepressant
effects in the forced swim test (Galeotti et al., 2006; Galeotti and
Ghelardini, 2011). There is also evidence suggesting that chronic
FIGURE 8 | Locomotor response to acute SKF83822. (A,B) represent the
ambulatory distance traveled by each genotype in response to an acute
injection of the dopamine D1 receptor agonist SKF83822 (0.4mg/kg; i.p.).
There is a significant increase in locomotor activity in each genotype
following exposure to SKF83822 [F(5, 18) = 139.2, p < 0.001]. There is,
however, a significant difference between the locomotor response of the
knockouts compared to the other two genotypes [F(5, 18) = 139.2,
p < 0.001] without significant changes in the percentage change from
baseline between the genotypes (C). n = 6–12 for each genotype in these
experiments.
stress in rodent models alters transcript levels of Gnaq (Alfonso
et al., 2006); another implication of alterations in Gαq signaling
in rodent models of depression. It is possible, however, to acti-
vate these signaling pathways via other mechanisms including
signaling initiated by Gα11 coupling which remains intact in the
Gαq knockout animals.
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FIGURE 9 | Locomotor response to acute SKF83959. SKF83959
(1mg/kg; i.p.), a dopamine D1 receptor agonist that has been reported to
activate D1 receptors coupled to Gαq, significantly increases locomotor
activity in Gαq knockout, heterozygous, and wildtype mice (A,B;
F(5, 18) = 123.9, p < 0.001). There is also a significant difference in the
post-injection locomotor response of the null mice compared to their
wildtype and heterozygous littermates (B; F(5, 18) = 123.9, p < 0.001) and a
significant difference in the percentage change from baseline of the
knockouts [C; F(2, 33) = 7.0, p < 0.05] and heterozygotes [F(2, 33) = 7.0,
p < 0.001] compared to wildtype. n = 12–18 for each genotype.
The Y-maze task is often employed as a test of spatial work-
ing memory whereby mice will alternate between the three arms
of the maze based on their interest in exploring the novel envi-
ronment and their memory of the last arm entered. The influence
of the prefrontal cortex in spontaneous alternation behaviors has
previously been demonstrated in rodent models (Kolb, 1984) in
FIGURE 10 | Locomotor response to acute MK-801. The NMDA receptor
antagonist MK-801 (0.2mg/kg; i.p.) induced a significant locomotor
response in wildtype and heterozygous mice [F(5, 36) = 9.8, p < 0.05] but
not in Gαq knockouts (A,B). Additionally, there were no significant changes
observed in the percentage change from baseline between the genotypes
(C). n = 6–12 for each genotype in these experiments.
addition to the roles of other brain regions including the hip-
pocampus, basal forebrain, dorsal striatum, and cerebellum in
mediating this behavior (Lalonde, 2002). We observed significant
differences in the ability of the Gαq knockout mice to perform
this task indicating that functional Gαq signaling in the prefrontal
cortex may be necessary for acquisition of this task. These results
are interesting with respect to the extensive literature detailing the
importance of catecholamine signaling, in particular the role of
dopamine, in mediating prefrontal cortex function, and working
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memory (Vijayraghavan et al., 2007; Arnsten, 2011). Additionally,
there is evidence in the literature suggesting that dopamine D1
receptors in the prefrontal cortex are able to couple to Gαq (Jin
et al., 2001) and thus the performance of the Gαq null mice
could be explained by lack of dopamine signaling in this path-
way. Alternatively, lack of signaling through other Gαq-coupled
receptors in the cortex could be contributing to the observed
phenotype.
In evaluating the intactness of the basal ganglia locomotor
circuitry, we assessed the drug-induced locomotor responses of
wildtype, heterozygous, and Gαq null animals to a variety of
pharmacologic compounds. The psychostimulant cocaine acts
indirectly to increase dopaminergic signaling by blocking the
dopamine transporter, thus inhibiting dopamine re-uptake into
pre-synaptic nerve terminals. As a result, dopamine accumulates
at MSN synapses in the dorsal striatum, thus increasing and
prolonging receptor activation primarily through D1 receptors
signaling in the direct motor pathway to increase locomotor out-
put (Kolb, 1984; Karasinska et al., 2005; Bateup et al., 2010). We
were successful in generating locomotor responses in all three
genotypes in response to acute cocaine suggesting that the func-
tioning of the basal ganglia motor pathways remains largely intact
in the absence of Gαq. Although Gαq protein expression does
not appear to be necessary for the acute locomotor response to
cocaine, it does appear to be involved in the expression of cocaine
withdrawal in rodent models. It has previously been shown that
rats undergoing withdrawal for 2 days after receiving twice-daily
cocaine injections (15mg/kg; i.p.) exhibited increased levels of
membrane-associated Gα11 and Gαq proteins in the amygdala
after 1 or 3 days (for peak expression, respectively) of cocaine
exposure (Carrasco et al., 2004). Additionally, following 5 days
of cocaine treatment, membrane-bound Gα11 and Gαq were also
increased in the paraventricular nucleus of the hypothalamus
(Carrasco et al., 2004), but no changes were observed in brain
regions such as the frontal cortex even after 14 days of cocaine
exposure (Carrasco et al., 2003, 2004). These changes in Gα11 and
Gαq protein expression are transient, however, and are reversed
back to baseline levels when assessed after 7 days of withdrawal
(Carrasco et al., 2003).
We were also successful in generating a locomotor response in
Gαq knockout mice by directly stimulating dopamine D1 recep-
tors in the direct motor output pathway with the D1 receptor
partial agonists SKF83822 and SKF83959. These results were
expected with SKF83822 as this compound has been previ-
ously shown to produce a locomotor response typical of classical
dopamine agonists stimulating adenylyl cyclase activity (Peacock
and Gerlach, 2001; O’Sullivan et al., 2004). Interestingly, how-
ever, we also observed a locomotor response in Gαq knockout
mice following administration of SKF83959, a dopamine D1
receptor agonist that has been reported to activate D1 receptors
coupled to PI hydrolysis, and intracellular calcium mobilization.
Previous reports assessing the behavioral effects of SKF83959 have
shown the drug to elicit intense grooming behavior and oro-
facial movements in rodent models (Downes and Waddington,
1993; Fujita et al., 2010) and prove effective in reversing parkin-
sonian symptoms in rodent (unilateral 6-OHDA lesioned) and
non-human primate (MPTP treated) models of Parkinson’s
disease (Arnt et al., 1992; Gnanalingham et al., 1995a,b,c;
Zhang et al., 2007).
One recent hypothesis in the literature detailing a mecha-
nism by which SKF83959 stimulates PI activity involves activat-
ing a D1/D2 receptor dimer complex coupled to Gαq protein
(Rashid et al., 2007) and subsequent signaling systems. We there-
fore expected to observe minimal SKF83959-induced locomotor
responses in Gαq knockoutmice, if in fact, SKF83959 does activate
D1 receptors signaling through Gαq. Contrary to our hypotheses,
however, SKF83959-induced locomotor responses were intact in
Gαq null animals. In fact, when their different baselines are taken
into account, Gαq heterozygous and knockout mice may actually
be more sensitive to the effects of the SKF83959 in that both geno-
types exhibited a significantly greater percentage change from
baseline in their post-injection locomotor response compared
to wildtype animals. Taken together, these results suggest that
SKF83959 may not be exclusively activating receptors coupled to
the Gαq signaling pathway. The most likely explanation is that
SKF83959 is not a selective as thought, andmay activate D1 recep-
tors coupled to Gαs/olf signaling pathways. It is conceivable that
even if SKF83959 does activate D1-Gαs/olf coupled receptors, there
could be alternative cyclase-independent pathways feeding into
IP3 dependent-calcium mobilization that would support the ini-
tial biochemical characterization of this drug (Arnt et al., 1992;
Andringa et al., 1999; Jin et al., 2003).
Our attempts to induce a significant locomotor response in
Gαq knockout mice by modulating glutamatergic tone with the
non-competitive NMDA receptor antagonist MK-801 proved
unsuccessful. Experiments using this MK-801 were designed to
indirectly modulate locomotor output as descending glutamater-
gic inputs from the cortex project to the striatum where they
synapse on the dendritic spines of MSNs in close proximity
to the synaptic contacts of the ascending midbrain dopamine
neurons from the SN pars compacta. The glutamatergic and
dopaminergic nerve terminals form synaptic triads where they
contact MSNs: points of contact whereby the two signaling sys-
tems likely converge to modulate MSN output (Schmidt and
Kretschmer, 1997; Jason et al., 2011). Additionally, there is evi-
dence suggesting that MK-801 produces indirect activation of
dopaminergic neurons to dose-dependently induce locomotor
activity up to 0.5mg/kg with a peak response around 0.2mg/kg.
At higher doses of MK-801 (>0.5mg/kg) a characteristic motor
syndrome is produced involving ataxia and stereotypic behav-
iors including head weaving and body rolling (Liljequist et al.,
1991). Although the locomotor response induced by MK-801
was not statistically significant in the null animals in our assess-
ments, there was a trend toward increased activity in these
mice. In addition, the response observed in the wildtype ani-
mals was fairly modest after a 0.2mg/kg exposure and it may
be necessary to move to slightly higher doses for a more robust
response. At higher doses, however, other behaviors are also
elicited which could confound the clarity of the locomotor
response. Furthermore, there is some evidence suggesting that
proper postnatal signaling of the Gαq-coupled mGluR1 recep-
tor is required for proper maturation of glutamatergic synapses
in the ventral tegmental area, a midbrain nucleus containing
dopaminergic cell bodies (Bellone et al., 2011). A mechanism
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such as this could potentially be necessary in other brain regions
and may partially explain the results observed in the Gαq knock-
out mice.
CONCLUSIONS
We have replicated and extended findings showing clear motor
deficits in Gαq knockout mice as assessed on an accelerating
rotarod and the inverted screen test. Also, we have shown that
Gαq knockout mice exhibit a significant hypoactive phenotype
in the Y-maze, elevated zero maze and the open field, further
supporting deficits in motor output. Drug-induced locomotor
activity in Gαq knockout mice, however, remains intact with stim-
ulation by dopaminergic agonists but not with the glutamatergic
antagonist, MK-801. These findings indicate that basal ganglia
locomotor circuitry is largely functional in the absence of Gαq sig-
naling capacity. Motor impairments in these animals, therefore,
likely originate in the cerebellum or other brain regions impor-
tant in initiating motor output or discrete regions in areas such as
the thalamus that are involved in signal integration and relay of
motor signals to the cortex.
Additionally, we observed normal phenotypes in both the ele-
vated zero maze and the forced swim test indicating that anxiety
and depression-related circuitry appears intact after loss of Gαq
expression. Lastly, use of the Y-maze revealed spatial memory
deficits in Gαq knockout mice, indicating that functional Gαq-
coupled receptor signaling is necessary for proficiency in this task,
most likely in the prefrontal cortex. However, our use a global
mutant line and systemic injections clearly requires a very cautious
interpretation, particularly with regard to specific brain regions.
ACKNOWLEDGMENTS
This work was supported by RO1MH086629 (Gregg D.
Stanwood), F31DA029499 (Aliya L. Frederick), the Vanderbilt
Kennedy Center and the Vanderbilt Brain Institute. Behavioral
work was performed at the Vanderbilt Mouse Neurobehavioral
Core which is supported in part by P30HD15052. We thank Dr.
Stefan Offermanns (University of Heidelberg, Germany) for sup-
plying the Gαq mutant line. We also thank Matt Buendia, Heather
Durai and Dr. John Allison for excellent technical assistance and
Dr. Devon Graham for reading the manuscript.
REFERENCES
Albin, R. L., Young, A. B., and Penney,
J. B. (1995). The functional anatomy
of disorders of the basal ganglia.
Trends Neurosci. 18, 63–64.
Alfonso, J., Frick, L. R., Silberman, D.
M., Palumbo, M. L., Genaro, A. M.,
and Frasch, A. C. (2006). Regulation
of hippocampal gene expression is
conserved in two species subjected
to different stressors and antide-
pressant treatments. Biol. Psychiatry
59, 244–251.
Andringa, G., Drukarch, B., Leysen,
J. E., Cools, A. R., and Stoof, J.
C. (1999). The alleged dopamine
D1 receptor agonist SKF 83959 is
a dopamine D1 receptor antagonist
in primate cells and interacts with
other receptors. Eur. J. Pharmacol.
364, 33–41.
Arnsten, A. F. (2011). Catecholamine
influences on dorsolateral pre-
frontal cortical networks. Biol.
Psychiatry 69, e89–e99.
Arnt, J., Hyttel, J., and Sanchez, C.
(1992). Partial and full dopamine
D1 receptor agonists in mice and
rats: relation between behavioural
effects and stimulation of adeny-
late cyclase activity in vitro. Eur.
J. Pharmacol. 213, 259–267.
Aupperle, R. L., and Paulus, M. P.
(2010). Neural systems underlying
approach and avoidance in anxiety
disorders. Dialogues Clin. Neurosci.
12, 517–531.
Bateup, H. S., Santini, E., Shen, W.,
Birnbaum, S., Valjent, E., Surmeier,
D. J., Fisone, G., Nestler, E. J.,
and Greengard, P. (2010). Distinct
subclasses of medium spiny neu-
rons differentially regulate striatal
motor behaviors. Proc. Natl. Acad.
Sci. U.S.A. 107, 14845–14850.
Bellone, C., Mameli, M., and Luscher,
C. (2011). In utero exposure to
cocaine delays postnatal synaptic
maturation of glutamatergic trans-
mission in the VTA. Nat. Neurosci.
14, 1439–1446.
Carrasco, G. A., Damjanoska, K. J.,
D’Souza, D. N., Zhang, Y., Garcia,
F., Battaglia, G., Muma, N. A., and
van de Kar, L. D. (2004). Short-
term cocaine treatment causes neu-
roadaptive changes in Galphaq and
Galpha11 proteins in rats undergo-
ing withdrawal. J. Pharmacol. Exp.
Ther. 311, 349–355.
Carrasco, G. A., Zhang, Y.,
Damjanoska, K. J., D’Souza, D.
N., Garcia, F., Battaglia, G., Muma,
N. A., and van de Kar, L. D.
(2003). A region-specific increase
in Galphaq and Galpha11 proteins
in brains of rats during cocaine
withdrawal. J. Pharmacol. Exp. Ther.
307, 1012–1019.
Chudasama, Y. (2011). Animal mod-
els of prefrontal-executive function.
Behav. Neurosci. 125, 327–343.
Clark, D. A., and Beck, A. T. (2010).
Cognitive theory and therapy of
anxiety and depression: conver-
gence with neurobiological findings.
Trends Cogn. Sci. 14, 418–424.
Clark, L., Chamberlain, S. R.,
and Sahakian, B. J. (2009).
Neurocognitive mechanisms in
depression: implications for treat-
ment. Annu. Rev. Neurosci. 32,
57–74.
Cools, A. R., Lubbers, L., van Oosten,
R. V., and Andringa, G. (2002). SKF
83959 is an antagonist of dopamine
D1-like receptors in the prefrontal
cortex and nucleus accumbens: a
key to its antiparkinsonian effect
in animals? Neuropharmacology 42,
237–245.
Cotecchia, S. (2010). The alpha1-
adrenergic receptors: diversity of
signaling networks and regulation.
J. Recept. Signal Transduct. Res. 30,
410–419.
Downes, R. P., and Waddington, J. L.
(1993). Grooming and vacuous
chewing induced by SK&F 83959,
an agonist of dopamine ‘D1-like’
receptors that inhibits dopamine-
sensitive adenylyl cyclase. Eur.
J. Pharmacol. 234, 135–136.
Drevets, W. C., Price, J. L., and Furey,
M. L. (2008). Brain structural and
functional abnormalities in mood
disorders: implications for neu-
rocircuitry models of depression.
Brain Struct. Funct. 213, 93–118.
Etkin, A. (2010). Functional neu-
roanatomy of anxiety: a neural cir-
cuit perspective. Curr. Top. Behav.
Neurosci. 2, 251–277.
Exton, J. H. (1996). Regulation of
phosphoinositide phospholipases
by hormones, neurotransmitters,
and other agonists linked to G
proteins. Annu. Rev. Pharmacol.
Toxicol. 36, 481–509.
Fujita, S., Kiguchi, M., Kobayashi,
M., Kinsella, A., Koshikawa, N.,
and Waddington, J. L. (2010).
Assessment of jaw movements
by magnetic sensor in relation to
topographies of orofacial behaviour
in freely moving rats: studies with
the dopamine D(1)-like receptor
agonists SKF 83822 vs SKF 83959.
Eur. J. Pharmacol. 632, 39–44.
Galeotti, N., Bartolini, A., and
Ghelardini, C. (2006). Blockade of
intracellular calcium release induces
an antidepressant-like effect in
the mouse forced swimming test.
Neuropharmacology 50, 309–316.
Galeotti, N., and Ghelardini, C.
(2011). Antidepressant phenotype
by inhibiting the phospholi-
pase Cbeta(1)–protein kinase
Cgamma pathway in the forced
swim test. Neuropharmacology 60,
937–943.
Gerfen, C. R. (1992). The neostriatal
mosaic: multiple levels of com-
partmental organization. Trends
Neurosci. 15, 133–139.
Gnanalingham, K. K., Erol, D. D.,
Hunter, A. J., Smith, L. A., Jenner,
P., and Marsden, C. D. (1995c).
Differential anti-parkinsonian
effects of benzazepine D1 dopamine
agonists with varying efficacies in
the MPTP-treated common mar-
moset. Psychopharmacology (Berl.)
117, 275–286.
Gnanalingham, K. K., Hunter, A. J.,
Jenner, P., and Marsden, C. D.
(1995a). Stimulation of adenylate
cyclase activity by benzazepine D-1
dopamine agonists with varying
efficacies in the 6-hydroxydopamine
lesioned rat–relationship to circling
behaviour. Biochem. Pharmacol. 49,
1185–1193.
Gnanalingham, K. K., Hunter, A.
J., Jenner, P., and Marsden, C.
D. (1995b). The differential
behavioural effects of benzazepine
D1 dopamine agonists with varying
efficacies, co-administered with
quinpirole in primate and rodent
models of Parkinson’s disease.
Frontiers in Behavioral Neuroscience www.frontiersin.org June 2012 | Volume 6 | Article 29 | 11
Frederick et al. Behavior of Gαq null mice
Psychopharmacology (Berl.) 117,
287–297.
Goldman-Rakic, P. S. (1995). Cellular
basis of working memory. Neuron
14, 477–485.
Harro, J., Kanarik, M., Matrov, D.,
and Panksepp, J. (2011). Mapping
patterns of depression-related brain
regions with cytochrome oxidase
histochemistry: relevance of animal
affective systems to human disor-
ders, with a focus on resilience to
adverse events. Neurosci. Biobehav.
Rev. 35, 1876–1889.
Jason, K., Ariel, D., Roger, C., and
Danny, W. (2011). “Synaptic triad
in the neostriatum,” in Dopamine –
Glutamate Interactions in the Basal
Ganglia, ed S. Jones (New York, NY:
CRC Press), 71–104.
Jin, L. Q., Goswami, S., Cai, G.,
Zhen, X., and Friedman, E. (2003).
SKF83959 selectively regulates
phosphatidylinositol-linked D1
dopamine receptors in rat brain.
J. Neurochem. 85, 378–386.
Jin, L. Q., Wang, H. Y., and Friedman,
E. (2001). Stimulated D(1)
dopamine receptors couple to
multiple Galpha proteins in differ-
ent brain regions. J. Neurochem. 78,
981–990.
Karasinska, J. M., George, S. R.,
Cheng, R., and O’Dowd, B. F.
(2005). Deletion of dopamine D1
and D3 receptors differentially
affects spontaneous behaviour
and cocaine-induced locomotor
activity, reward and CREB phos-
phorylation. Eur. J. Neurosci. 22,
1741–1750.
Kesner, R. P., and Churchwell, J. C.
(2011). An analysis of rat prefrontal
cortex in mediating executive func-
tion. Neurobiol. Learn. Mem. 96,
417–431.
Kessler, R. C., Berglund, P., Demler,
O., Jin, R., Merikangas, K. R.,
and Walters, E. E. (2005). Lifetime
prevalence and age-of-onset distri-
butions of DSM-IV disorders in
the National Comorbidity Survey
Replication. Arch. Gen. Psychiatry
62, 593–602.
Kolb, B. (1984). Functions of the
frontal cortex of the rat: a com-
parative review. Brain Res. 320,
65–98.
Lalonde, R. (2002). The neurobiologi-
cal basis of spontaneous alternation.
Neurosci. Biobehav. Rev. 26, 91–104.
Liljequist, S., Ossowska, K.,
Grabowska-Anden, M., and
Anden, N. E. (1991). Effect of
the NMDA receptor antagonist,
MK-801, on locomotor activity and
on the metabolism of dopamine in
various brain areas of mice. Eur.
J. Pharmacol. 195, 55–61.
Lister, R. G. (1990). Ethologically-based
animal models of anxiety disorders.
Pharmacol. Ther. 46, 321–340.
Mailleux, P., Mitchell, F.,
Vanderhaeghen, J. J., Milligan, G.,
and Erneux, C. (1992). Immuno-
histochemical distribution of
neurons containing the G-proteins
Gq alpha/G11 alpha in the adult rat
brain.Neuroscience 51, 311–316.
McEwen, B. S., Eiland, L., Hunter,
R. G., and Miller, M. M. (2012).
Stress and anxiety: structural
plasticity and epigenetic regula-
tion as a consequence of stress.
Neuropharmacology 62, 3–12.
Millan, M. J., Marin, P., Bockaert,
J., and Mannoury la Cour, C.
(2008). Signaling at G-protein-
coupled serotonin receptors: recent
advances and future research direc-
tions. Trends Pharmacol. Sci. 29,
454–464.
Milligan, G. (1993). Regional distribu-
tion and quantitative measurement
of the phosphoinositidase C-linked
guanine nucleotide binding proteins
G11 alpha and Gq alpha in rat brain.
J. Neurochem. 61, 845–851.
Nakano, K. (2000). Neural circuits
and topographic organization of the
basal ganglia and related regions.
Brain Dev. 1(Suppl. 22), S5–S16.
O’Sullivan, G. J., Roth, B. L., Kinsella,
A., and Waddington, J. L. (2004).
SK&F 83822 distinguishes adeny-
lyl cyclase from phospholipase
C-coupled dopamine D1-like
receptors: behavioural topog-
raphy. Eur. J. Pharmacol. 486,
273–280.
Offermanns, S., Heiler, E., Spicher,
K., and Schultz, G. (1994). Gq
and G11 are concurrently activated
by bombesin and vasopressin in
Swiss 3T3 cells. FEBS Lett. 349,
201–204.
Offermanns, S., Toombs, C. F., Hu,
Y. H., and Simon, M. I. (1997a).
Defective platelet activation in G
alpha(q)-deficient mice.Nature 389,
183–186.
Offermanns, S., Hashimoto, K.,
Watanabe, M., Sun, W., Kurihara,
H., Thompson, R. F., Inoue,
Y., Kano, M., and Simon, M. I.
(1997b). Impaired motor coor-
dination and persistent multiple
climbing fiber innervation of cere-
bellar Purkinje cells in mice lacking
Galphaq. Proc. Natl. Acad. Sci.
U.S.A. 94, 14089–14094.
Offermanns, S., Zhao, L. P., Gohla,
A., Sarosi, I., Simon, M. I., and
Wilkie, T. M. (1998). Embryonic
cardiomyocyte hypoplasia and cran-
iofacial defects in G alpha q/G
alpha 11-mutant mice. EMBO J. 17,
4304–4312.
Panchalingam, S., and Undie, A. S.
(2001). SKF83959 exhibits bio-
chemical agonism by stimulating
[(35)S]GTP gamma S binding
and phosphoinositide hydrol-
ysis in rat and monkey brain.
Neuropharmacology 40, 826–837.
Peacock, L., and Gerlach, J. (2001).
Aberrant behavioral effects of a
dopamine D1 receptor antagonist
and agonist in monkeys: evidence
of uncharted dopamine D1 recep-
tor actions. Biol. Psychiatry 50,
501–509.
Pin, J. P., and Duvoisin, R. (1995).
The metabotropic glutamate recep-
tors: structure and functions.
Neuropharmacology 34, 1–26.
Porsolt, R. D., Bertin, A., and Jalfre, M.
(1977). Behavioral despair in mice:
a primary screening test for antide-
pressants. Arch. Int. Pharmacodyn.
Ther. 229, 327–336.
Rashid, A. J., So, C. H., Kong, M. M.,
Furtak, T., El-Ghundi, M., Cheng,
R., O’Dowd, B. F., and George, S. R.
(2007). D1-D2 dopamine receptor
heterooligomers with unique phar-
macology are coupled to rapid acti-
vation of Gq/11 in the striatum.
Proc. Natl. Acad. Sci. U.S.A. 104,
654–659.
Ribeiro, F. M., Paquet, M., Cregan,
S. P., and Ferguson, S. S. (2010).
Group I metabotropic glutamate
receptor signalling and its implica-
tion in neurological disease. CNS
Neurol. Disord. Drug Targets 9,
574–595.
Rinaldi, A., Mandillo, S., Oliverio, A.,
and Mele, A. (2007). D1 and D2
receptor antagonist injections in
the prefrontal cortex selectively
impair spatial learning in mice.
Neuropsychopharmacology 32,
309–319.
Rodgers, R. J., Cao, B. J., Dalvi, A., and
Holmes, A. (1997). Animal mod-
els of anxiety: an ethological per-
spective. Braz. J. Med. Biol. Res. 30,
289–304.
Schmidt, W. J., and Kretschmer, B. D.
(1997). Behavioural pharmacology
of glutamate receptors in the basal
ganglia. Neurosci. Biobehav. Rev. 21,
381–392.
Shepherd, J. K., Grewal, S. S.,
Fletcher, A., Bill, D. J., and
Dourish, C. T. (1994). Behavioural
and pharmacological characterisa-
tion of the elevated “zero-maze”
as an animal model of anxi-
ety. Psychopharmacology (Berl.) 116,
56–64.
Shuen, J. A., Chen, M., Gloss, B.,
and Calakos, N. (2008). Drd1a-
tdTomato BAC transgenic mice
for simultaneous visualization
of medium spiny neurons in the
direct and indirect pathways of
the basal ganglia. J. Neurosci. 28,
2681–2685.
Smrcka, A. V., Hepler, J. R., Brown,
K. O., and Sternweis, P. C.
(1991). Regulation of polyphos-
phoinositide-specific phospholipase
C activity by purified Gq. Science
251, 804–807.
Stanwood, G. D., and Levitt, P. (2007).
Waved-1 mutant mice are hypersen-
sitive to the locomotor actions of
cocaine. Synapse 61, 259–262.
Stanwood, G. D., Parlaman, J. P., and
Levitt, P. (2005). Anatomical abnor-
malities in dopaminoceptive regions
of the cerebral cortex of dopamine
D1 receptor mutant mice. J. Comp.
Neurol. 487, 270–282.
Strathmann, M., and Simon, M. I.
(1990). G protein diversity: a dis-
tinct class of alpha subunits is
present in vertebrates and inverte-
brates. Proc. Natl. Acad. Sci. U.S.A.
87, 9113–9117.
Taylor, S. J., Chae, H. Z., Rhee, S. G.,
and Exton, J. H. (1991). Activation
of the beta 1 isozyme of phospho-
lipase C by alpha subunits of the
Gq class of G proteins. Nature 350,
516–518.
Thompson, B. L., Levitt, P., and
Stanwood, G. D. (2005). Prenatal
cocaine exposure specifically alters
spontaneous alternation behavior.
Behav. Brain Res. 164, 107–116.
Undie, A. S., Weinstock, J., Sarau,
H. M., and Friedman, E. (1994).
Evidence for a distinct D1-like
dopamine receptor that couples
to activation of phosphoinositide
metabolism in brain. J. Neurochem.
62, 2045–2048.
Vijayraghavan, S., Wang, M.,
Birnbaum, S. G., Williams, G.
V., and Arnsten, A. F. (2007).
Inverted-U dopamine D1 receptor
actions on prefrontal neurons
engaged in working memory. Nat.
Neurosci. 10, 376–384.
Wang, H. Y., Undie, A. S., and
Friedman, E. (1995). Evidence for
the coupling of Gq protein to D1-
like dopamine sites in rat striatum:
possible role in dopamine-mediated
inositol phosphate formation. Mol.
Pharmacol. 48, 988–994.
Weissman, M.M., Bland, R. C., Canino,
G. J., Faravelli, C., Greenwald, S.,
Hwu, H. G., Joyce, P. R., Karam, E.
G., Lee, C. K., Lellouch, J., Lepine,
J. P., Newman, S. C., Rubio-Stipec,
M., Wells, J. E., Wickramaratne, P.
J., Wittchen, H., and Yeh, E. K.
(1996). Cross-national epidemiol-
ogy of major depression and bipolar
disorder. JAMA 276, 293–299.
White, L. K., Helfinstein, S. M., Reeb-
Sutherland, B. C., Degnan, K. A.,
Frontiers in Behavioral Neuroscience www.frontiersin.org June 2012 | Volume 6 | Article 29 | 12
Frederick et al. Behavior of Gαq null mice
and Fox, N. A. (2009). Role of atten-
tion in the regulation of fear and
anxiety. Dev. Neurosci. 31, 309–317.
Wilkie, T. M., Scherle, P. A.,
Strathmann, M. P., Slepak, V.
Z., and Simon, M. I. (1991).
Characterization of G-protein
alpha subunits in the Gq class:
expression in murine tissues and
in stromal and hematopoietic cell
lines. Proc. Natl. Acad. Sci. U.S.A.
88, 10049–10053.
Zhang, H., Ma, L., Wang, F., Chen,
J., and Zhen, X. (2007). Chronic
SKF83959 induced less severe
dyskinesia and attenuated L-DOPA-
induced dyskinesia in 6-OHDA-
lesioned rat model of Parkinson’s
disease. Neuropharmacology 53,
125–133.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 09 March 2012; accepted: 29
May 2012; published online: 19 June
2012.
Citation: Frederick AL, Saborido TP and
Stanwood GD (2012) Neurobehavioral
phenotyping of Gαq knockout mice
reveals impairments in motor functions
and spatial working memory without
changes in anxiety or behavioral despair.
Front. Behav. Neurosci. 6:29. doi:
10.3389/fnbeh.2012.00029
Copyright © 2012 Frederick, Saborido
and Stanwood. This is an open-access
article distributed under the terms of
the Creative Commons Attribution Non
Commercial License, which permits
non-commercial use, distribution, and
reproduction in other forums, provided
the original authors and source are
credited.
Frontiers in Behavioral Neuroscience www.frontiersin.org June 2012 | Volume 6 | Article 29 | 13
